JP2025513344A5 - - Google Patents

Info

Publication number
JP2025513344A5
JP2025513344A5 JP2024561808A JP2024561808A JP2025513344A5 JP 2025513344 A5 JP2025513344 A5 JP 2025513344A5 JP 2024561808 A JP2024561808 A JP 2024561808A JP 2024561808 A JP2024561808 A JP 2024561808A JP 2025513344 A5 JP2025513344 A5 JP 2025513344A5
Authority
JP
Japan
Prior art keywords
treatment composition
ophthalmic treatment
composition according
ophthalmic
api
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024561808A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513344A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/065956 external-priority patent/WO2023205695A1/en
Publication of JP2025513344A publication Critical patent/JP2025513344A/ja
Publication of JP2025513344A5 publication Critical patent/JP2025513344A5/ja
Pending legal-status Critical Current

Links

JP2024561808A 2022-04-21 2023-04-19 眼科用局所クリーム組成物 Pending JP2025513344A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263363356P 2022-04-21 2022-04-21
US63/363,356 2022-04-21
PCT/US2023/065956 WO2023205695A1 (en) 2022-04-21 2023-04-19 Ophthalmic topical cream compositions

Publications (2)

Publication Number Publication Date
JP2025513344A JP2025513344A (ja) 2025-04-24
JP2025513344A5 true JP2025513344A5 (cg-RX-API-DMAC7.html) 2026-03-24

Family

ID=86558713

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024561808A Pending JP2025513344A (ja) 2022-04-21 2023-04-19 眼科用局所クリーム組成物

Country Status (7)

Country Link
US (2) US12414938B2 (cg-RX-API-DMAC7.html)
EP (1) EP4511001A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025513344A (cg-RX-API-DMAC7.html)
CN (1) CN119584954A (cg-RX-API-DMAC7.html)
AU (1) AU2023257375A1 (cg-RX-API-DMAC7.html)
CA (1) CA3249922A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023205695A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026060434A1 (en) * 2024-09-16 2026-03-19 Iview Therapeutics, Inc. Novel eyelid delivery of ophthalmic composition containing muscarinic receptor modulators for prevention and treatment of ocular disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2752008T3 (es) 2009-10-30 2020-04-02 Intratus Inc Métodos y composiciones para la liberación sostenida de fármacos
US20120195969A1 (en) 2010-09-29 2012-08-02 Aidan Research And Consulting, Llc Treatment of acne by conditioned media
DK2645993T3 (en) 2010-12-03 2017-02-13 Allergan Inc Pharmaceutical cream compositions comprising oxymetazoline
BR112015031885A2 (pt) 2013-06-18 2017-07-25 Lubrizol Advanced Mat Inc dispersões estáveis coloidalmente com base em galactomananas modificadas
CN113559105B (zh) 2014-01-29 2026-06-23 维奥姆治疗有限公司 抗性痤疮的治疗
US20170266289A1 (en) * 2014-08-27 2017-09-21 Abbvie Inc. Topical formulation
US20170087199A1 (en) 2016-02-10 2017-03-30 Senomyx, Inc. Compositions for delivering a cooling sensation
CA3032695C (en) * 2016-08-19 2021-11-23 Akrivista, LLC Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
US11160780B2 (en) * 2016-09-30 2021-11-02 Aurobindo Pharma Ltd. Pharmaceutical composition of ivermectin and process for preparation thereof
JP6946575B2 (ja) 2018-04-24 2021-10-06 アラーガン、インコーポレイテッドAllergan,Incorporated 眼の状態の治療のためのピロカルピン塩酸塩の使用
DK3870170T3 (da) * 2018-10-26 2026-05-26 Opus Genetics Inc Behandling af presbyopi og mydriasis med fentolamin
WO2020141482A1 (en) * 2019-01-04 2020-07-09 Glenmark Specialty S.A. Pharmaceutical compositions comprising mupirocin
NZ781774A (en) * 2019-03-08 2023-03-31 Taro Pharma Ind Stable topical compositions of fenoldopam
US20220071924A1 (en) * 2019-03-19 2022-03-10 Sol-Gel Technologies Ltd. Treatment of ocular diseases with ophthalmic tapinarof compositions
WO2024026365A1 (en) 2022-07-26 2024-02-01 Glaukos Corporation Ophthalmic topical cream formulations and uses thereof

Similar Documents

Publication Publication Date Title
JP5118633B2 (ja) 医療用デバイスおよび医薬製剤において有用な粘膜付着性キシログルカン含有製剤
JPH04500798A (ja) 硫酸化糖類の用途
JP2014533238A (ja) 老眼、弱度の遠視、および不正乱視を治療する組成物およびその治療方法
CN108601768A (zh) 用于治疗老花眼的组合物
Billowria et al. Topical advances in mucoadhesive ocular drug delivery system
CN109982692A (zh) 用于治疗眼表疾病的制剂和相关方法
KR101599447B1 (ko) 조성물 및 항문 치열 치료에서의 그 용도
TW201815397A (zh) 眼科用劑、眼科用藥、以及(a)羥丙基甲基纖維素及(b)維生素e類的用途
US20250387372A1 (en) Ophthalmic topical cream compositions and methods
JP2022547231A5 (cg-RX-API-DMAC7.html)
AU2009306462B2 (en) Urea-based film-forming solution for treating nail psoriasis
JP2024505517A (ja) 製剤
KR102073825B1 (ko) 자동 도포기에 의한 구강건조 개선용 가식성 히알루론산염 필름의 제조방법 및 이로부터 제조된 구강건조 개선용 가식성 히알루론산염 필름
CN105833278A (zh) 用于治疗口腔干燥和口腔疾病的组合物
I Tartara et al. New mucoadhesive polymeric film for ophthalmic administration of acetazolamide
CN106943590A (zh) 一种包含ngf的用于治疗角膜上皮损伤的药物组合物
CN102198087B (zh) 一种不含防腐剂的眼用原位胶凝剂及其制备方法
CN101084017B (zh) 具有循序渐进的释放的生物附着合成物
CN112316108B (zh) 促进及治疗慢性伤口愈合的组合物和方法
WO2005039567A1 (en) Pharmaceutical compositions comprising alpha-2-adrenergics and trefoil factor family peptides
CN103083354A (zh) 一种复方氯化钠滴眼液
CN107137698A (zh) 一种包含gdnf的用于治疗角膜上皮损伤的药物组合物
TWI918634B (zh) 治療的新用途及方法
CN117180236B (zh) 一种皮肤瘙痒症治疗用组合物、制剂及其制备方法和用途
CN102366439B (zh) 一种治疗慢性单纯性鼻炎的自热式中药贴膏剂